navigation
Ongoing Collaboration Projects
| Name | PI and coord. centre | SHCS representiatives | Topic | Region |
| ACHIeV2E A collaboration on HIV-2 infection | Linda Wittkop, France | J. Böni (lab), A. Calmy (clinic) | Diagnosis, natural history, and ART of HIV-2 Infection | 13 cohorts from Europe, Africa, North America |
| ATHENA, AQUITAINE, ICONA, ARCA 5 European cohort collaboration SHCS #816 | Flaminia Olearo, HUG | A. Calmy, R. Kouyos | The impact of mutations on the effectiveness of abacavir/lamivudine/dolutegravir regimens prescribed in treatment-experienced patients | Europe |
| BEEHIVE Bridging the evolution and epidemiology of HIV in Europe | Christoph Fraser, Oxford University, Oxford | H. Günthard, R. Kouyos | Evolution and Epidemiology of HIV in Europe | European Community (UK, Netherlands, Switzerland) |
| Causal effect of treatment on survival from HIV/AIDS | O. Aalen, Norway, J. Sterne, Bristol Univ, UK | B. Ledergerber | ||
| Cellular Immune Responses and Immuneactivation against HIV | A. Oxenius, ETHZ | H. Günthard | Study cellular immune responses and activation of CD4 and CD8 cells | |
| Effect of TDF on HCC incidence | A. Rauch, G. Wandeler | A. Rauch | Assessing the effect of HBV therapy on HCC in HIV-infected patients | Europe |
| EPPICC European Pregnancy and Paediatric HIV Cohort Collaboration | T. Klimkait | |||
| HBV outcomes in HIV/HBV-coinfected nd HBV-monoinfected patients in Switzerland | G. Wandeler | A. Rauch | Comparison of HBV virological outcomes between HIV and HIV-uninfected individuals | |
| HIV CAUSAL HIV Causal Collaboration #498 | M. Hernan, Harvard School of Public Health, Boston, USA | H. Bucher, M. Egger | When to start HAART? Best initial regimen? When to switch HAART? | 12 cohorts from USA and Europe |
| ICGH International Collaboration for the Genomics of HIV | a consortium of 25 cohorts / studies coordinated by the SHCS | J. Fellay | A collaborative research effort of all groups active in host genomics of HIV disease | America, Europe, Africa, Australia |
| IeDEA-hepatitis Long-term hepatitis B outcomes in HIV-infected patients in southern Africa and Switzerland | G. Wandeler, ISPM Bern | G. Wandeler, A. Rauch | HIV/HBV-coinfection cohorts | sub-Saharan Africa |
| Kinetics of Hepatitis B Virus markers in treated HIV/HBV-coinfected patients | G. Wandeler, ISPM Bern | G. Wandeler, A. Rauch | Assessing the dynamics of HBV markers in HIV/HBV coinfected patients | Europe |
| LoHRA Low HBV Replication and Adherence in Long-term TDF/&ETV-treated HIV-HBV infected patients | K. Lacombe, Paris | A. Rauch, G. Wandeler | Evaluating impact of low-level HBV replication in HIV-infected patients | Europe |
| Mathematical modelling and spread of HIV drug resistance at the population level in the SHCS | S. Bonhoeffer, ETHZ, T. Stadler, ETHZ | H. Günthard | Poplulation mathematical modelling of spread of HIV drug resistance on the population level | |
| Modelling hepatitis C treatment-as-preventions strategies | A. Rauch | A. Rauch, L. Salazar | Evaluation treatment-as-prevention to curb the HCV epidemics | Australia |
| Multi-cohort study to inform hepatocellular carcinoma screening strategies in HIV/HBV-coinfected individuals on tenofovir-containing therapy | G. Wandeler, ISPM Bern | G. Wandeler, A. Rauch | Investigating and improving progonstic score for HCC screening in HIV-infected patients | Europe |
| Multiple projects in Tanzania | Swiss Tropical and Public Health Institute, Basel | M. Battegay, H. Furrer | Tanzania | |
| NESCent The evolution of virulence in a human infectious disease: the case study of HIV | J. Herbeck, V. Müller | H. Günthard | HIV virulence over time in large global cohort collaborations | several Western European, American and most likely also African cohorts |
| Penta-EICG European infant collaboration | C. Gianquinto, Fondazion Penta-Onlus, Padova, Italy | C. Rudin, P. Paioni | Treatment of children | several European |
| PopGen Population kinetic modelling of metabolic traits in HIV-infected individuals | C. Czajka, University of Lausanne | P. Tarr | Development of a population kinetics model to describe the dynamics and interindividual variability of metabolic traits after ART initiation | |
| Principals of collaboration with the National Institute for Cancer Epidemiology and Registration (NICER) | R. Heusser, NICER | M. Egger | Linkage study with Swiss CR | |
| RESPOND International Cohort Consortium on Infectious Diseases | Amanda Mocroft, Jens Lundgren | H. Günthard, A. Scherrer | Long term outcomes in HIIV-infected individuals: aging, comorbididies, ART etc. | Europe |
| TB:HIV Co-infection with mycobacterium tuberculosis among HIV patients P501 and P663 | Jens Lundgren, CHIP, DK | H. Furrer | Co-infection with TB | several Eastern & Western European |